| 產(chǎn)品編號 | bsm-61441R | 
| 英文名稱 | Cathepsin B Recombinant Rabbit mAb | 
| 中文名稱 | 組織蛋白酶B重組兔單抗 | 
| 別 名 | APPS; Cathepsin B heavy chain; Cathepsin B1; CathepsinB; CPSB; CTSB; cysteine protease; Preprocathepsin B. | 
| 抗體來源 | Rabbit | 
| 克隆類型 | Recombinant | 
| 克 隆 號 | 14C12 | 
| 交叉反應(yīng) | Human | 
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,IHC-P=1:50-200,IHC-F=1:50-200,IF=1:50-200,ICC/IF=1:50-200,IP=1:20-50
 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.  | 
| 理論分子量 | 38 kDa | 
| 檢測分子量 | 38 | 
| 性 狀 | Liquid | 
| 免 疫 原 | A synthesized peptide derived from human Cathepsin B: 2-180 | 
| 亞 型 | IgG | 
| 純化方法 | affinity purified by Protein A | 
| 緩 沖 液 | 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. | 
| 保存條件 | Store at 4℃ for short term. Store at -20℃ for long term. Avoid repeated freeze/thaw cycles. | 
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. | 
| PubMed | PubMed | 
| 產(chǎn)品介紹 | 
Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Cleaves matrix extracellular phosphoglycoprotein MEPE. Involved in the solubilization of cross-linked TG/thyroglobulin in the thyroid follicle lumen. SWISS: P07858 Gene ID: 1508 合成與降解(Synthesis and Degradation) 組織蛋白酶B(CB) 參與腫瘤的侵襲轉(zhuǎn)移過程??纱龠M(jìn)腫瘤血管的增生,增強(qiáng)腫瘤細(xì)胞的運(yùn)動能力.組織蛋白酶B轉(zhuǎn)錄以及表達(dá)水平的高低與腫瘤預(yù)后呈正相關(guān)。 cathepsin B屬于半胱氨酸蛋白酶,與人體的多種生理、病理過程密切相關(guān).組織蛋白酶B (cathepsin B,CB)主要存在于溶酶體中, 發(fā)揮其生理狀態(tài)下的蛋白水解作用.但在某些特定條件下, CB在胞外間質(zhì)中有時也可以檢測到. 目前,有學(xué)者將CB用于阿爾茨海默?。ˋ  | 
| 產(chǎn)品圖片 | 
 
25 ug total protein per lane of various lysates (see on figure) probed with Cathepsin B monoclonal antibody, unconjugated (bsm-61441R) at 1:2000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
 
Paraformaldehyde-fixed, paraffin embedded Human Thymus; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
Paraformaldehyde-fixed, paraffin embedded Human Kidney; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
Paraformaldehyde-fixed, paraffin embedded Human Cerebrum; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
Paraformaldehyde-fixed, paraffin embedded Human Breast Cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
Paraformaldehyde-fixed, paraffin embedded Human Ovarian Cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
Paraformaldehyde-fixed, paraffin embedded Human Colon Cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Cathepsin B Monoclonal Antibody, Unconjugated(bsm-61441R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
 
 |